GET DAILY SIGNALSMarex Group (MRX) Delivers Record Q3 Revenue with +53% Year-over-Year Growth
Key Takeaways
- Marex Group reported record quarterly revenue of $743.2 million for Q3 2026, up 53% year over year from $484.6 million.
- Earnings per share (EPS) came in at $1.67, comfortably above the Wall Street consensus estimate of $1.52.
- Adjusted profit before tax (PBT) rose 75% year over year to $176.1 million, with the adjusted PBT margin expanding to 23.7%.
- Growth was broad-based across all four business segments, led by a more-than-doubling of net trading income to $420.2 million.
- Revenue beat the consensus estimate of $677.5 million by roughly 9.7%, while EPS exceeded expectations by nearly 10%.
Why These Results Matter
Marex Group Limited (MRX) operates as a diversified global financial services platform offering liquidity, market access, and infrastructure across commodities and financial markets. Its quarterly updates provide timely insight into trading volumes, client activity, and performance across clearing, agency and execution, market making, and hedging operations. The company approached this release after beating estimates in each of the previous three quarters, so the Q3 2026 numbers served as an important check on whether momentum could hold amid changing volatility and higher interest costs.
Breaking Down the Reported Numbers
Revenue reached a record $743.2 million in the third quarter of 2026, marking a 53% rise from $484.6 million a year earlier and topping the consensus forecast of $677.5 million by about 9.7%. EPS climbed to $1.67 from $0.96 in the prior-year quarter and surpassed the $1.52 analyst estimate by roughly 9.9%.
Net trading income more than doubled to $420.2 million from $197.7 million, reflecting strength across Agency and Execution, Market Making, and Hedging and Investment Solutions. Net commission income increased $20.4 million to $252.6 million. Segment revenue showed Agency and Execution at $361.1 million, Clearing at $170.1 million, Market Making at $150.8 million, and Hedging and Investment Solutions at $61.2 million. I also checked this using Tickeron’s AI Screener to compare performance against peers in the sector.
Adjusted profit before tax grew 75% year over year to $176.1 million, lifting the adjusted PBT margin to 23.7%. Profit after tax rose $57.1 million to $130.3 million.
Market Reaction and Investor Sentiment
Investor sentiment was already constructive ahead of the release, given the string of prior beats. The results reinforced that view, with both revenue and EPS clearing expectations and broad strength across segments supporting margin expansion. The stock had seen some modest pullback in the weeks leading up to the report, so attention quickly turned to management’s comments on integration progress and whether the growth pace can be maintained. Focus now centers on the durability of trading-related income and the path for adjusted margins.
Forward Outlook and Factors to Watch
Looking ahead, the key question is whether Marex can sustain its elevated revenue run rate. Management noted that October activity was running close to the annual average, with the usual seasonal slowdown expected around the holidays. The 2027 budget outlook calls for adjusted PBT growth of 10% to 20%, including the full-year impact from recent acquisitions such as Winterflood, Levmet, and Web Traders.
Margin expansion continues to be a priority, with a longer-term target in the mid-20% range supported by scale in Prime and Clearing, operational efficiencies, and potential productivity gains. Net interest income remains an area to monitor, as it declined despite higher average balances because rising interest expense offset the balance growth. Several pending acquisitions in clearing and prime services across Asia and Latin America are expected to close in Q4 2026 or Q1 2027, with limited financial contribution until the second half of 2027. Broader market volatility and client onboarding trends will also influence whether the current momentum extends into the next fiscal year.
Using AI Tools in My Research Process
When evaluating earnings releases like this one, I find it helpful to run quick scans for comparable companies and technical setups. Tickeron’s AI Screener lets me filter across fundamentals, patterns, and signals in a single workflow, which can surface additional context without manual effort. It has become a regular part of how I cross-check ideas before forming a fuller view.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
MRX in +8.38% Uptrend, advancing for three consecutive days on November 04, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where MRX advanced for three days, in 152 of 175 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 20 of 27 cases where MRX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.
MRX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MRX as a result. In 32 of 44 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 73%.
MRX moved below its 50-day moving average on October 16, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for MRX crossed bearishly below the 50-day moving average on October 19, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 2 of 3 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 67%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MRX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.
The Aroon Indicator for MRX entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 16 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 35 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. MRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.498) is normal, around the industry mean (3.123). P/E Ratio (11.357) is within average values for comparable stocks, (6.767). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.809). Dividend Yield (0.010) settles around the average of (9.201) among similar stocks. P/S Ratio (1.260) is also within normal values, averaging (16.899).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry InvestmentBanksBrokers
Advertisement